Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Stem Cell Research News

Seaweed Transformed Into Stem Cell Technology - Engineers Develop Degradable Scaffold That Releases Stem Cells In The Body

Main Category: Stem Cell Research
Also Included In: Medical Devices / Diagnostics
Article Date: 09 Nov 2007 - 14:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 and a half stars

4.33 (6 votes)

Health Professional:4 and a half stars

4.5 (2 votes)

Article Opinions: 1 posts

Engineers at Rensselaer Polytechnic Institute have transformed a polymer found in common brown seaweed into a device that can support the growth and release of stem cells at the sight of a bodily injury or at the source of a disease.

The findings, which are detailed in the December 2007 edition of Biomaterials, mark an important step in efforts to develop new medical therapies using stem cells.

"We have developed a scaffold for stem cell culture that can degrade in the body at a controlled rate," said lead researcher Ravi Kane, professor of chemical and biological engineering. "With this level of control we can foster the growth of stem cells in the scaffold and direct how, when, and where we want them to be released in the body."

Kane and his collaborators, which include the author of the paper and former Rensselaer graduate student Randolph Ashton, created the device from a material known as alginate. Alginate is a complex carbohydrate found naturally in brown seaweed. When mixed with calcium, alginate gels into a rigid, three-dimensional mesh.

The device could have wide-ranging potential for use in regenerative medicine, Kane explains. For example, the scaffolds could one day be used in the human body to release stem cells directly into injured tissue. Kane and his colleagues hope that the scaffold could eventually be used for medical therapies such as releasing healthy bone stem cells right at the site of a broken bone, or releasing neural stem cells in the brain where cells have been killed by diseases such as Alzheimer's.

Kane and his team encapsulated healthy neural stem cells in the alginate mesh, producing a three-dimensional scaffold that degrades at a tunable, controlled rate. Once the scaffold is implanted in the body, the researchers use an enzyme called alginate lyase, which eats away at alginate, to release the stem cells. Alginate lyase is naturally produced in some marine animals and bacterial strains, but not in humans.

In order to control the degradation of the alginate scaffold, the researchers encapsulated varying amounts of alginate lyase into microscale beads, called microspheres. The microspheres containing the alginate lyase were then encapsulated into the larger alginate scaffolds along with the stem cells. As the microspheres degraded, the alginate lyase enzyme was released into the larger alginate scaffold and slowly began to eat away at its surface, releasing the healthy stem cells in a controlled fashion.

The microspheres also can be filled with more than just alginate lyase. "We can add drug molecules or proteins to the microspheres along with the alginate lyase that, when released into the larger alginate scaffold, could influence the fate of the encapsulated stem cells," Kane said. "By adding these materials to the larger scaffold, we can direct the stem cells to become the type of mature, differentiated cell that we desire, such as a neuron. This will prove very valuable for applications of stem cells in regenerative medicine."

Kane and Ashton were assisted in their research by Professor David V. Schaffer of the University of California at Berkeley; Akhilesh Banerjee, a Rensselaer graduate student; and Supriya Punyani, a Rensselaer postdoctoral associate.

The research was funded with a grant from New York state.

About Rensselaer

Rensselaer Polytechnic Institute, founded in 1824, is the nation's oldest technological university. The university offers bachelor's, master's, and doctoral degrees in engineering, the sciences, information technology, architecture, management, and the humanities and social sciences. Institute programs serve undergraduates, graduate students, and working professionals around the world. Rensselaer faculty are known for pre-eminence in research conducted in a wide range of fields, with particular emphasis in biotechnology, nanotechnology, information technology, and the media arts and technology. The Institute is well known for its success in the transfer of technology from the laboratory to the marketplace so that new discoveries and inventions benefit human life, protect the environment, and strengthen economic development.

  Rensselaer Polytechnic Institute




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Scientists Make Human Sperm From Embryonic Stem Cells
08 Jul 2009
UK scientists have announced this week that they have found a way to make human sperm from embryonic stem cells in a laboratory, a breakthrough that they hope will help us better understand the causes of infertility...


The Latest on LASIK
The Latest on LASIK

The latest technology gives doctors the ability to map the surface of a patient's eye. That unique map then guides the laser that reshapes the eye. But this technology comes at a price.

more videos are available in our health videos section.